ArticleOncotarget2017

Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis.

Hsi-Wen Yeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.